KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Basic) (2016 - 2025)

Gilead Sciences (GILD) has disclosed EPS (Basic) for 17 consecutive years, with $1.76 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 23.94% year-over-year to $1.76, compared with a TTM value of $6.84 through Dec 2025, up 1748.65%, and an annual FY2025 reading of $6.84, up 1700.0% over the prior year.
  • EPS (Basic) was $1.76 for Q4 2025 at Gilead Sciences, down from $2.45 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.45 in Q3 2025 and bottomed at -$3.34 in Q1 2024.
  • Average EPS (Basic) over 5 years is $1.02, with a median of $1.25 recorded in 2021.
  • The sharpest move saw EPS (Basic) surged 3950.0% in 2023, then plummeted 512.35% in 2024.
  • Year by year, EPS (Basic) stood at $0.31 in 2021, then surged by 322.58% to $1.31 in 2022, then fell by 12.21% to $1.15 in 2023, then grew by 23.48% to $1.42 in 2024, then grew by 23.94% to $1.76 in 2025.
  • Business Quant data shows EPS (Basic) for GILD at $1.76 in Q4 2025, $2.45 in Q3 2025, and $1.57 in Q2 2025.